Dr. Deepak Kumar Honaganahalli, MD

Dr. Honaganahalli practices at UCHealth Medical Group in Loveland, Colorado.

Dr. Honaganahalli's NPI, 1619114337, was assigned on January 16, 2009. Dr. Honaganahalli holds Colorado license DR.0047606.

Dr. Honaganahalli's primary practice is UCHealth Medical Group, at 2695 Rocky Mountain Ave, Loveland, CO 80538 in Larimer County. The practice phone is (970) 624-4443.

Dr. Honaganahalli's primary practice is UCHealth Medical Group in Loveland, Colorado. Dr. Honaganahalli is also affiliated with UCHealth University of Colorado Hospital. The medical group on file is UCHealth Medical Group. Dmand AI also links Dr. Honaganahalli to 1 more hospital, 1 group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Honaganahalli practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Honaganahalli's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Honaganahalli's licenses on file in 2 states: Colorado and Massachusetts.

CMS data shows 1,147 Medicare services from Dr. Honaganahalli across 16 procedure codes in 2024, for 251 Medicare patients. Medicare paid $49,113 for them. Every service was in an office.

CMS counts 251 Medicare patients who saw Dr. Honaganahalli in 2024. The largest group is 65 to 74, with 141 patients. 75% of them have high cholesterol, and 64% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Honaganahalli's median patient age at 65, with 41% women.

In 2024, Dr. Honaganahalli wrote 3,524 Medicare Part D claims for 378 patients. 88% of them were for generic drugs. CMS names the drug for 2,827 of them, across 60 drugs with 11 or more claims each, at $238,280 in total drug cost. In 2023, CMS named 2,318 claims across 57 drugs.

Dr. Honaganahalli accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Honaganahalli as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 57 general payments to Dr. Honaganahalli from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $1,075.